A neuromodulation system includes a conductive element, a magnetic field generator, a power module and a computer processor. The conductive element located internal a patient's body. At least a portion of the conductive element is positioned adjacent to a target tissue. The magnetic field generator is positioned external to the patient's body. The magnetic field generator generates a time varying magnetic field for inducing stimulation of the target tissue in combination with the conductive element to produce stimulation that is larger than that which would occur in the absence of the conductive element. The power module supplies power to the magnetic field generator. The computer processor controls the time varying magnetic field provided by the magnetic field generator according to at least one set of stimulation parameters.

A system for mapping neuromuscular junctions for botulinum neurotoxin (BoNT) injections includes a stimulation electrode and an electromyography (EMG) sensor array including EMG sensors configured to be arranged about a person's face. Each EMG sensor detects muscle activity of a facial muscle of a facial muscle group. An EMG amplifier includes a plurality of input channels. Each input channel receives data of facial muscle activity in the facial muscle group from the EMG sensor array. A computer is in communication with the EMG amplifier. A processor of the computer identifies neuromuscular junctions (NMJs) of the facial muscle group based on the data of facial muscle activity received from the EMG sensor array. The plurality of NMJs are mapped with respect to the at least one facial muscle group of the body of the person. At least one NMJ site for BoNT injection is recommended by the computer.

A multi-type combination electrical stimulation method is for medical treatment of surface and internal infected tissues, surface wounds and ulcers, trauma injuries, abnormal plasia and fibrotic changes, and pain conditions. The multi-type electrotherapy system for non-invasive treatment of both surface and deep body bacterial and viral infections and wound healing includes a machine learning function optimization task algorithm, and a stimulation device electronically with the ability to generate carrier base waveforms with amplitude modulation of these waveforms by secondary frequencies. The ranges of such frequencies are base frequencies in the range of 1-20,000 Hz and modulating frequencies in the range of 1-200 Hz. The waveforms are generated by either direct digital synthesis (DDS) or digital to analogue (DAC) converter electronics.

A transcutaneous electrical stimulation system is provided that can include a number of features. In one implementation, the system can include a plurality of electrodes configured to be in contact with a skin surface of a patient. The system can further include a flexible hub electrically connected to the electrodes and configured to be in contact with the patient. A bend sensor can be disposed in the hub and configured to measure a curvature of the hub. The system can include a signal processing device electrically coupled to the plurality of electrodes and the bend sensor, the signal processing device being configured to change stimulation settings of the plurality of electrodes based on the curvature of the hub. In some implementations, the system can include a multi-channel stimulator. Methods of use are also provided.

A system including a galvanic stimulator, and an eye tracking device, wherein the system is a clinical vestibular implant suitability evaluation system. The system includes a computing apparatus configured analyze eye tracking data generated by the eye tracking device and provide output indicative of the analysis. The system is configured to evoke a vestibular reflex in a human with at least a partially functioning neural system of the human's vestibular system.

A method of providing electrical stimulation to a patient, to treat a disorder from which the patient suffers, includes: detecting respiration of the patient with a sensor; and repeatedly administering electrical stimulations to a target site of the patient. Suitably, the repeated administration of said electrical stimulations is automatically synchronized with the respiration of the patient as detected by the sensor.

A device, system, and method for facilitating a sleep cycle in a subject suing a peri COVID vaccination period, comprising determining a current awake or sleep stage of a person; automatically defining a desired sleep cycle pattern, dependent on the current awake or sleep stage of the person; generating an audio or optical stimulation pattern by an automated processor; entraining brainwaves of the brain of the person with the stimulation pattern corresponding to the desired sleep cycle pattern, to thereby induce a sleep cycle in the person according to the sleep cycle pattern; and administering the SARS-Cov-2 vaccination to the person.

A system for fecal propulsion includes one or more sensors, a stimulator, one or more pairs of electrodes, a controller and a programming device. The sensors detect at least one marker of colonic activity from the enteric, autonomic and/or somatic nervous system. The stimulator generates energy of a particular waveform, intensity and/or time-course to modulate targeted neural circuitry with stimulation parameters being adaptable and dynamic to accommodate the various types of modulated tissues. The electrodes deliver stimulation to the enteric, autonomic and/or somatic nervous systems to control fecal propulsion. The controller and programing device change the stimulation parameters in real-time based on sensor feedback to acutely drive the circuitry from rest to productive defecation. The stimulation waveforms can be simultaneously or sequentially delivered to condition some tissues, while modulating others. The system is adaptive and can be driven through a data analytic repository and machine learning algorithm.

An electrical interferential technique is used to determine operable treatment parameters which are then used to apply a treatment to a patient. A range of beat frequencies is applied to the patient and an indicator of autonomic nervous system activity is measured. When some degree of autonomic nervous system activity is detected, a subsequent trial is conducted using an overlaying range of frequencies, a narrower range or a single frequency, in an attempt to fine tune the reaction of the autonomic nervous system. The subsequent trial may use a different measure of activity of the autonomic nervous system. A garment having a series of electrode sites thereon may be used for a partially trained person to correctly apply electrodes to the patient's body. The treatments may be conducted while the patient is asleep.

A system includes ultrasound transducers configured to generate and direct ultrasound beams at a region within a portion of a subject's brain, sensors configured to measure a response from the portion of the subject's brain in response to one or more ultrasound beams, and an electronic controller in communication with the ultrasound transducers configured to generate, based on a measured response from the portion of the subject's brain in response to two or more ultrasound beams generated from two or more different angles, a model of the portion of the subject's brain, wherein the model has a higher resolution than a maximum resolution of a single ultrasound beam, and generate, based on the model of the portion of the subject's brain, stimulation parameters for the ultrasound transducers to generate and direct a stimulation ultrasound beam at the region within the portion of the subject's brain.